Head-to-Head Comparison of [ 68 Ga]Ga-DOTATATE PET/CT and [ 68 Ga]Ga-NODAGA-LM3 PET/CT
Journal of Nuclear Medicine · 2026
DOI: 10.2967/jnumed.125.271074 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Journal of Nuclear Medicine, 2026. Verfasst von Canan Can und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Gazi Yasargil Training and Research Hospital, Diyarbakir, Turkey; and canancankarahan@gmail.com. Hauptthemen laut MEDLINE: Organometallic Compounds, Positron Emission Tomography Computed Tomography, Acetates, Heterocyclic Compounds, 1-Ring. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 33 Literaturangaben.
Abstract (Originalsprache)
This study compared the physiologic distribution of [68Ga]Ga-DOTATATE and [68Ga]Ga-NODAGA-LM3 PET/CT, assessed SUV and tumor-to-background ratio (TBR) measurements in primary and metastatic lesions, and evaluated lesion detection performance.
Methods
Forty-one adult patients with well-differentiated (G1-G3) gastroenteropancreatic or lung neuroendocrine neoplasms, pheochromocytoma, medullary thyroid carcinoma, and well-differentiated thyroid carcinoma were included in this study. All patients underwent PET/CT imaging with both [68Ga]Ga-DOTATATE and [68Ga]Ga-NODAGA-LM3 within a 3-d interval. SUVmax and SUVmean were calculated for physiologic uptake regions, and SUVmax and TBR were determined for lesions. Paired data were analyzed using the paired-samples t test or Wilcoxon signed-rank test, with a P of less than 0.05 considered statistically significant.
Results
The median patient age was 62 y (range, 27-90 y), and 63.4% were women. Analysis of uptake in normal organs revealed that [68Ga]Ga-DOTATATE PET/CT demonstrated significantly higher physiologic activity in the liver, spleen, pancreas, and jejunum, whereas [68Ga]Ga-NODAGA-LM3 showed significantly higher uptake in the parotid glands, mediastinal blood pool, lungs, breasts, kidneys, and uterus. Lesion-based analysis found that [68Ga]Ga-NODAGA-LM3 detected significantly more liver metastases than did [68Ga]Ga-DOTATATE (P < 0.05), with no significant differences observed in other regions. The TBR of liver metastases was significantly higher with [68Ga]Ga-NODAGA-LM3 (P = 0.006), although the SUVmax did not significantly differ between radiotracers. Conclusion: [68Ga]Ga-NODAGA-LM3 demonstrates a higher TBR and superior detection of liver metastases compared with [68Ga]Ga-DOTATATE. Although no significant differences were found in other regions, the 2 radiotracers exhibit distinct physiologic distribution patterns.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nuclear Medicine, Gazi Yasargil Training and Research Hospital, Diyarbakir, Turkey; and canancankarahan@gmail.com.
- Department of Nuclear Medicine, Gazi Yasargil Training and Research Hospital, Diyarbakir, Turkey; and.
- Department of Internal Medicine, Division of Medical Oncology, Gazi Yasargil Training and Research Hospital, Diyarbakir, Turkey.
Zitieren
APA
Can, C., Kömek, H., Güzel, Y., Akdeniz, N., Karaoğlan, H., Kaplan, İ., Güzel, F., Yeprem, Ö., Akyıldız, E., & Kepenek, F. (2026). Head-to-Head Comparison of [ 68 Ga]Ga-DOTATATE PET/CT and [ 68 Ga]Ga-NODAGA-LM3 PET/CT. Journal of Nuclear Medicine. https://doi.org/10.2967/jnumed.125.271074
Vancouver
Can C, Kömek H, Güzel Y, Akdeniz N, Karaoğlan H, Kaplan İ, et al. Head-to-Head Comparison of [ 68 Ga]Ga-DOTATATE PET/CT and [ 68 Ga]Ga-NODAGA-LM3 PET/CT. Journal of Nuclear Medicine. 2026. doi:10.2967/jnumed.125.271074
BibTeX
@article{Can2026,
author = {Can, Canan and Kömek, Halil and Güzel, Yunus and Akdeniz, Nadiye and Karaoğlan, Hüseyin and Kaplan, İhsan and Güzel, Fatih and Yeprem, Ömer and Akyıldız, Erkan and Kepenek, Ferat},
title = {Head-to-Head Comparison of [ 68 Ga]Ga-DOTATATE PET/CT and [ 68 Ga]Ga-NODAGA-LM3 PET/CT},
journal = {Journal of Nuclear Medicine},
year = {2026},
doi = {10.2967/jnumed.125.271074}
}
EUVIMED